MedTrace Logo

Optimal Value Increase of Egg Products

NCT04606628 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2022-01-21

No results posted yet for this study

Summary

The aim of this project is to evaluate daily intake of eggshell membrane taken as supplement (capsule), will reduce markers of inflammation in older people.

Conditions

Interventions

OTHER

Eggshell membrane (ESM)

The intervention group will consume two capsules containing (in total) 500mg ESM with breakfast every day in 4 weeks.

OTHER

Placebo

The placebo group will consume two placebo capsules (Cellulose) with breakfast every day in 4 weeks

Sponsors & Collaborators

  • Nofima

    collaborator OTHER

  • Norwegian University of Life Sciences

    collaborator OTHER

  • Nortuna

    collaborator UNKNOWN

  • Norilia

    collaborator UNKNOWN

  • Orkla

    collaborator UNKNOWN

  • Danægg

    collaborator UNKNOWN

  • University of Oslo

    lead OTHER

Principal Investigators

  • Stine M Ulven, PhD · University of Oslo

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
70 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-15
Primary Completion
2021-10-01
Completion
2021-10-01

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04606628 on ClinicalTrials.gov